178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Researchers urge arthritis patients to give up smoking to help them live longer

Researchers urge arthritis patients to give up smoking to help them live longer

by University of ManchesterCredit: Artem Podrez from PexelsUniversity of Manchester-led research has found new evidence to suggest that, not only is smoking associated with earlier deaths i

Researchers urge arthritis patients to give up smoking to help them live longer

by University of ManchesterCredit: Artem Podrez from PexelsUniversity of Manchester-led research has found new evidence to suggest that, not only is smoking associated with earlier deaths i
First-in-human trial with CAR macrophages shows promise targeting solid tumors

First-in-human trial with CAR macrophages shows promise targeting solid tumors

by Caren Begun,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainPreliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability a

First-in-human trial with CAR macrophages shows promise targeting solid tumors

by Caren Begun,University of PennsylvaniaCredit: Pixabay/CC0 Public DomainPreliminary findings from Penn Medicine in an ongoing first-in-human clinical trial examining the safety, tolerability a
BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs

by The Wistar InstituteL-R: Wistar Drs. Mohamed Abdel-Mohsen and Luis Montaner Credit: The Wistar InstituteSpearheaded by scientists at The Wistar Institute, top worldwide HIV researchers from th

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs

by The Wistar InstituteL-R: Wistar Drs. Mohamed Abdel-Mohsen and Luis Montaner Credit: The Wistar InstituteSpearheaded by scientists at The Wistar Institute, top worldwide HIV researchers from th
Proteinuria level predicts renal outcome in lupus nephritis

Proteinuria level predicts renal outcome in lupus nephritis

(HealthDay)—Proteinuria levels at 12 months are the best predictor of long-term renal outcome in patients with lupus nephritis, according to a study published in the May issue ofArthritis &

Proteinuria level predicts renal outcome in lupus nephritis

(HealthDay)—Proteinuria levels at 12 months are the best predictor of long-term renal outcome in patients with lupus nephritis, according to a study published in the May issue ofArthritis &
Delivery methods compared for osteoarthritis intervention

Delivery methods compared for osteoarthritis intervention

First-line intervention for hip or knee osteoarthritis (OA) may reduce pain whether delivered in-person or digitally, according to a study published online Nov. 3 inJAMA Network Open.Therese Jön

Delivery methods compared for osteoarthritis intervention

First-line intervention for hip or knee osteoarthritis (OA) may reduce pain whether delivered in-person or digitally, according to a study published online Nov. 3 inJAMA Network Open.Therese Jön
Long-term rituximab safe for patients with wegener's

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3

Long-term rituximab safe for patients with wegener's

Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; Wegener&#3
FDA approves first interchangeable biosimilar for inflammatory diseases

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),

FDA approves first interchangeable biosimilar for inflammatory diseases

(HealthDay)—The first interchangeable biosimilar product to Humira (adalimumab) was approved by the U.S. Food and Drug Administration on Oct. 15, the agency announced Monday.Cyltezo (adalimumab-adbm),
Takayasu arteritis, ulcerative colitis co-occurrence rate high

Takayasu arteritis, ulcerative colitis co-occurrence rate high

(HealthDay)—Takayasu arteritis (TAK) has a high rate of co-occurrence and genetic overlap with ulcerative colitis (UC), according to a study published in the August issue ofArthritis & Rheum

Takayasu arteritis, ulcerative colitis co-occurrence rate high

(HealthDay)—Takayasu arteritis (TAK) has a high rate of co-occurrence and genetic overlap with ulcerative colitis (UC), according to a study published in the August issue ofArthritis & Rheum
Vitamin D shows no impact on interferon response in SLE

Vitamin D shows no impact on interferon response in SLE

(HealthDay)—For patients with systemic lupus erythematosus (SLE), vitamin D3supplementation does not affect interferon (IFN) signature, according to a study published in the July issue ofA

Vitamin D shows no impact on interferon response in SLE

(HealthDay)—For patients with systemic lupus erythematosus (SLE), vitamin D3supplementation does not affect interferon (IFN) signature, according to a study published in the July issue ofA
Researchers call for improved accessibility to specialist medical services during health care crises

Researchers call for improved accessibility to specialist medical services during health care crises

by Keele UniversityCredit: Pixabay/CC0 Public DomainDelays for patients awaiting a diagnosis of an inflammatory arthritis, caused by changes in practice during the COVID pandemic, could have a ne

Researchers call for improved accessibility to specialist medical services during health care crises

by Keele UniversityCredit: Pixabay/CC0 Public DomainDelays for patients awaiting a diagnosis of an inflammatory arthritis, caused by changes in practice during the COVID pandemic, could have a ne
COVID-19 model reveals key role for innate immunity in controlling viral load

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N

COVID-19 model reveals key role for innate immunity in controlling viral load

by American Chemical SocietyColorized scanning electron micrograph of a cell (blue) heavily infected with SARS-CoV-2 virus particles (red), isolated from a patient sample. Image captured at the N
A new approach to study autoimmune diseases

A new approach to study autoimmune diseases

by Indiana Biosciences Research InstituteVenn diagrams of risk genes expressed in the target tissues of the fourautoimmune diseases (type 1 diabetes, systemic lupus erythematosus, multiple sclerosis,

A new approach to study autoimmune diseases

by Indiana Biosciences Research InstituteVenn diagrams of risk genes expressed in the target tissues of the fourautoimmune diseases (type 1 diabetes, systemic lupus erythematosus, multiple sclerosis,